VALERY BERGERON-DESIMONE: Open Payments
NPI 1801097704 · LAGUNA NIGUEL, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$974 in 33 payments from 12 companies in 2025. Trend: 2023 $18 · 2024 $184 · 2025 $974
Food & beverage: $974
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 6 | $210 |
| Amgen Inc. | 3 | $162 |
| Novo Nordisk Inc | 5 | $148 |
| Lilly USA, LLC | 6 | $120 |
| Xeris Pharmaceuticals, Inc. | 5 | $115 |
| RECORDATI_RARE_DISEASES_INC. | 2 | $64 |
| Corcept Therapeutics | 1 | $40 |
| Exact Sciences Corporation | 1 | $32 |
| Dexcom, Inc. | 1 | $29 |
| Tandem Diabetes Care, Inc. | 1 | $21 |
Products named: Omnipod, Wegovy, Repatha, MOUNJARO, RECORLEV, ISTURISA, OTEZLA, Korlym.
Industry payments across CA — which companies pay providers there.
